163 related articles for article (PubMed ID: 27890559)
1. Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit.
Hudon Thibeault AA; Laurent L; Vo Duy S; Sauvé S; Caron P; Guillemette C; Sanderson JT; Vaillancourt C
Mol Cell Endocrinol; 2017 Feb; 442():32-39. PubMed ID: 27890559
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Hudon Thibeault AA; López de Los Santos Y; Doucet N; Sanderson JT; Vaillancourt C
J Steroid Biochem Mol Biol; 2019 Dec; 195():105470. PubMed ID: 31509772
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of serotonergic 5-HT2A receptor signaling increases placental aromatase (CYP19) activity and expression in BeWo and JEG-3 human choriocarcinoma cells.
Klempan T; Hudon-Thibeault AA; Oufkir T; Vaillancourt C; Sanderson JT
Placenta; 2011 Sep; 32(9):651-656. PubMed ID: 21703684
[TBL] [Abstract][Full Text] [Related]
4. The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production.
Caron-Beaudoin E; Viau R; Hudon-Thibeault AA; Vaillancourt C; Sanderson JT
Toxicol Appl Pharmacol; 2017 Oct; 332():15-24. PubMed ID: 28750898
[TBL] [Abstract][Full Text] [Related]
5. Co-culture of H295R Adrenocortical Carcinoma and BeWo Choriocarcinoma Cells to Study Feto-placental Interactions: Focus on Estrogen Biosynthesis.
Thibeault AH; Sanderson JT; Vaillancourt C
Methods Mol Biol; 2018; 1710():295-304. PubMed ID: 29197012
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects on steroidogenesis of estragole and trans-anethole in a feto-placental co-culture model.
Yancu D; Vaillancourt C; Sanderson JT
Mol Cell Endocrinol; 2019 Dec; 498():110583. PubMed ID: 31536780
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization.
Clabault H; Flipo D; Guibourdenche J; Fournier T; Sanderson JT; Vaillancourt C
Toxicol Appl Pharmacol; 2018 Jun; 349():8-20. PubMed ID: 29679653
[TBL] [Abstract][Full Text] [Related]
8. Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.
Arumugasaamy N; Hurley-Novatny A; Lembong J; Kim PCW; Fisher JP
Acta Biomater; 2019 Nov; 99():258-268. PubMed ID: 31536839
[TBL] [Abstract][Full Text] [Related]
9. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
10. Essential oils disrupt steroidogenesis in a feto-placental co-culture model.
Yancu D; Sanderson T
Reprod Toxicol; 2019 Dec; 90():33-43. PubMed ID: 31425786
[TBL] [Abstract][Full Text] [Related]
11. The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study.
Bertrand PP; Paranavitane UT; Chavez C; Gogos A; Jones M; van den Buuse M
Brain Res; 2005 Dec; 1064(1-2):10-20. PubMed ID: 16298349
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Jacobsen NW; Hansen CH; Nellemann C; Styrishave B; Halling-Sørensen B
Toxicol In Vitro; 2015 Oct; 29(7):1729-35. PubMed ID: 26162595
[TBL] [Abstract][Full Text] [Related]
13. A unique co-culture model for fundamental and applied studies of human fetoplacental steroidogenesis and interference by environmental chemicals.
Hudon Thibeault AA; Deroy K; Vaillancourt C; Sanderson JT
Environ Health Perspect; 2014 Apr; 122(4):371-7. PubMed ID: 24486430
[TBL] [Abstract][Full Text] [Related]
14. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.
Hansen CH; Larsen LW; Sørensen AM; Halling-Sørensen B; Styrishave B
Toxicol In Vitro; 2017 Jun; 41():1-11. PubMed ID: 28179152
[TBL] [Abstract][Full Text] [Related]
15. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.
Pinna G; Costa E; Guidotti A
Psychopharmacology (Berl); 2006 Jun; 186(3):362-72. PubMed ID: 16432684
[TBL] [Abstract][Full Text] [Related]
17. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats.
Bourdeaux R; Desor D; Lehr PR; Younos C; Capolaghi B
J Pharm Pharmacol; 1998 Dec; 50(12):1387-92. PubMed ID: 10052854
[TBL] [Abstract][Full Text] [Related]
18. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
19. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
Wong DT; Bymaster FP; Reid LR; Mayle DA; Krushinski JH; Robertson DW
Neuropsychopharmacology; 1993 Jun; 8(4):337-44. PubMed ID: 8512621
[TBL] [Abstract][Full Text] [Related]
20. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
